Savara, Inc. is a high-risk, high-reward biotech focused solely on Molbreevi for treating aPAP. Click here to read why SVRA ...

The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, ...

Levi & Korsinsky, LLP notifies investors in Savara Inc. (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors ...

October 8, 2025) - If you suffered a loss on your Savara Inc. (NASDAQ: SVRA) investment and want to learn about a potential recovery under th ...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming November 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors ...

SVRA investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming November 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who ...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Savara Inc.(“Savara” or the “Company”) (NASDAQ: SVRA) securities between ...

Savara (SVRA) “announced the acceptance of two abstracts for poster presentation and one abstract as an oral presentation at CHEST 2025 in ...

NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) and certain officers. The ...

Virtual Meeting to be held on October 8-9 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving ...